Rate of change in early Huntington's dis
β
Christina Meyer; Bernhard Landwehrmeyer; Carsten Schwenke; Adam Doble; Michael O
π
Article
π
2011
π
John Wiley and Sons
π
English
β 389 KB
## Abstract Sensitive outcome measures for patients with Huntington's disease (HD) are required for future clinical trials. Longitudinal data were collected from a 3βyear study of 379 patients suffering from early HD who were not treated by antipsychotics. Progression of UHDRS item scores was evalu